| BLU 451 : Targeting Epidermal Growth Factor Receptor–Related Signaling Pathways in Pancreatic Cancer |
AG-120: Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120